Financial reports
ARS
2023 FY
Annual report to shareholders
24 Apr 24
10-K
2023 FY
Annual report
5 Mar 24
10-Q
2023 Q3
Quarterly report
7 Nov 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
ARS
2023 FY
Annual report to shareholders
24 Jul 23
10-Q
2023 Q1
Quarterly report
9 May 23
10-K
2022 FY
Annual report
14 Mar 23
10-Q
2022 Q3
Quarterly report
8 Nov 22
10-Q
2022 Q2
Quarterly report
5 Aug 22
Current reports
8-K
Departure of Directors or Certain Officers
8 Mar 24
8-K
Regulation FD Disclosure
5 Mar 24
8-K
Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results
5 Mar 24
8-K
Regulation FD Disclosure
8 Jan 24
8-K/A
Departure of Directors or Certain Officers
5 Jan 24
8-K
Results of Operations and Financial Condition
4 Jan 24
8-K
Departure of Directors or Certain Officers
26 Dec 23
8-K
Departure of Directors or Certain Officers
6 Dec 23
8-K
Axogen, Inc Reports 2023 Third Quarter Financial Results
7 Nov 23
8-K
Departure of Directors or Certain Officers
22 Sep 23
Registration and prospectus
S-3/A
Shelf registration (amended)
29 Mar 24
S-8
Registration of securities for employees
6 Mar 24
S-3
Shelf registration
6 Mar 24
POS AM
Prospectus update (post-effective amendment)
6 Mar 24
S-8
Registration of securities for employees
18 Aug 23
S-8
Registration of securities for employees
31 May 22
POS AM
Prospectus update (post-effective amendment)
25 Feb 22
POSASR
Automatic shelf registration (post-effective amendment)
25 Feb 22
S-8
Registration of securities for employees
11 May 21
S-3ASR
Automatic shelf registration
6 May 21
Proxies
DEF 14A
Definitive proxy
24 Apr 24
PRE 14A
Preliminary proxy
4 Apr 24
DEF 14A
Definitive proxy
7 Jul 23
PRE 14A
Preliminary proxy
21 Jun 23
DEF 14A
Definitive proxy
14 Apr 22
PRE 14A
Preliminary proxy
4 Apr 22
DEF 14A
Definitive proxy
31 Mar 21
DEF 14A
Definitive proxy
17 Apr 20
DEF 14A
Definitive proxy
27 Jun 19
DEFA14A
Additional proxy soliciting materials
30 Mar 18
Other
EFFECT
Notice of effectiveness
14 Mar 24
EFFECT
Notice of effectiveness
8 Apr 22
UPLOAD
Letter from SEC
16 Jun 20
CORRESP
Correspondence with SEC
22 May 20
UPLOAD
Letter from SEC
27 Apr 20
CT ORDER
Confidential treatment order
5 Mar 19
CT ORDER
Confidential treatment order
30 Mar 18
EFFECT
Notice of effectiveness
11 Oct 17
CORRESP
Correspondence with SEC
6 Oct 17
UPLOAD
Letter from SEC
4 Oct 17
Ownership
4
Karen L. Zaderej
25 Mar 24
4
Erick Wayne DeVinney
25 Mar 24
4
Angelo Scopelianos
25 Mar 24
4
Michael Patrick Donovan
25 Mar 24
4
Michael Patrick Donovan
8 Mar 24
4
Gregory Gene Freitag
8 Mar 24
144
Notice of proposed sale of securities
7 Mar 24
144
Notice of proposed sale of securities
7 Mar 24
4
Erick Wayne DeVinney
5 Mar 24
4
Jens Kemp
23 Feb 24